Cibus (NASDAQ:CBUS – Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.87) earnings per share for the quarter, missing the consensus estimate of ($0.68) by ($0.19), Zacks reports. Cibus had a negative net margin of 10,724.78% and a negative return on equity of 28.17%. The business had revenue of $1.21 million during the quarter, compared to analyst estimates of $1.13 million.
Cibus Stock Performance
CBUS opened at $2.05 on Friday. The firm’s fifty day moving average is $2.33 and its two-hundred day moving average is $3.35. The firm has a market cap of $54.23 million, a PE ratio of -0.09 and a beta of 2.04. Cibus has a twelve month low of $1.80 and a twelve month high of $23.18.
Analyst Ratings Changes
A number of research firms have recently weighed in on CBUS. Canaccord Genuity Group cut their price target on Cibus from $20.00 to $18.00 and set a “buy” rating on the stock in a research note on Wednesday, January 22nd. HC Wainwright reissued a “buy” rating and issued a $25.00 target price on shares of Cibus in a research note on Friday.
Hedge Funds Weigh In On Cibus
An institutional investor recently raised its position in Cibus stock. Bank of America Corp DE lifted its position in shares of Cibus, Inc. (NASDAQ:CBUS – Free Report) by 113.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 35,536 shares of the company’s stock after purchasing an additional 18,885 shares during the quarter. Bank of America Corp DE owned 0.13% of Cibus worth $99,000 at the end of the most recent reporting period. 33.81% of the stock is currently owned by hedge funds and other institutional investors.
Cibus Company Profile
Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.
Featured Articles
- Five stocks we like better than Cibus
- Stock Analyst Ratings and Canadian Analyst Ratings
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- What Are the U.K. Market Holidays? How to Invest and Trade
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- Insider Trading – What You Need to Know
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for Cibus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cibus and related companies with MarketBeat.com's FREE daily email newsletter.